Lactobacillus crispatus LBV 88 and Reduced Recurrence of Bacterial Vaginosis

• The right bug in the right place: opportunities for bacterial vaginosis treatment.

  • 2022-05-02
  • Review
  • NPJ biofilms and microbiomes 8(1)
  • • Shengru Wu
    • Luisa Warchavchik Hugerth
    • Ina Schuppe-Koistinen
    • Juan Du

  • PubMed: 35501321
  • DOI: 10.1038/s41522-022-00295-y

  1 Insight on

  • Reduced Recurrence of Bacterial Vaginosis

  • Low evidence

  Here, we propose a great opportunity for large clinical trials with probiotic strains isolated from the vaginal tract (e.g., Lactobacillus crispatus) and administered directly into the vagina after pretreatment.

  Effect

  Beneficial

  Effect size

  Moderate